The Board of Directors of UCrest Berhad ("UCrest" or "the Company") is pleased to announce that the Company has launched the world's first innovation with the integration of an AI Health-driven e-Commerce System into its iMedic™ Digital Health Platform, making it the first clinic management and telehealth system globally to combine patient consultations, prescriptions, and personalized, AI Health-based recommendations for medicines and supplements in a single seamless workflow.

With this enhancement, iMedic™ transforms from a digital healthcare management system into an integrated digital healthcare marketplace. Patients can consult doctors online and, upon receiving a prescription, purchase prescribed medicines as well as doctor-endorsed or recommended supplements directly within iMedic™. The AI Health-driven system analyses each patient’s personal medical data to provide tailored product and supplement recommendations, which patients can review and discuss with their doctors before making a purchase. Orders are fulfilled and shipped directly to patients, delivering a fully end-to-end digital healthcare experience that no other clinic management system in Asia—or globally—currently offers.

The integration creates new recurring revenue opportunities, including transaction-based fees, subscriptions, and potential partnerships with healthcare suppliers, while increasing patient engagement and system stickiness.

The AI Health-driven architecture is modular and scalable, allowing the iMedic™ system to expand across multiple healthcare segments, including pharmaceuticals, wellness supplements, and digital health services, as well as additional regional markets. This scalability enhances the system’s commercial value and solidifies UCrest’s leadership position in the digital health sector.

Multiple patents have been filed on these innovative technologies in the US, China, Europe, Taiwan, Singapore and Malaysia.

This announcement is dated 20 January 2026.